FDAnews
www.fdanews.com/articles/156979-fda-slow-to-ask-j-j-for-drug-data-lawyer-says

FDA Slow to Ask J&J for Drug Data, Lawyer Says

July 11, 2013
Philadelphia lawyer Steven Sheller wrote a letter to the FDA, claiming that the agency is not taking concerns over Johnson & Johnson’s antipsychotic drugs risperdal and invega seriously enough.
Philly.com